Advertisement

GI & Endoscopy

Advertisement

Dublin, Ireland-based Allergen had positive phase III results in its Viberzi study for treating irritable bowel syndrome with diarrhea, according to Wallstreet.org. The New England Journal of Medicine published the results in its Jan. 21 issue.

Advertisement